The role of m6A methylation in osteosarcoma biological processes and its potential clinical value

被引:0
作者
Yanjiao Wu
Zhiyun Wang
Jianlin Shen
Wei Yan
Shurong Xiang
Huan Liu
Wenhua Huang
机构
[1] Southern Medical University (The First People’s Hospital of Shunde),Shunde Hospital
[2] Southern Medical University,Guangdong Provincial Key Laboratory of Medical Biomechanics, School of Basic Medical Sciences
[3] Southern Medical University,Guangdong Engineering Research Center for Translation of Medical 3D Printing Application
[4] Southern Medical University,Guangdong Innovation Platform for Translation of 3D Printing Application
[5] Affiliated Traditional Chinese Medicine Hospital,Department of Orthopaedics
[6] Southwest Medical University,The Precision Medicine Institute, The Third Affiliated Hospital
[7] Southern Medical University,Department of Anatomy
[8] Hebei Medical University,undefined
来源
Human Genomics | / 16卷
关键词
m6A modification; Osteosarcoma; Epigenetics; Writers; Erasers; Readers;
D O I
暂无
中图分类号
学科分类号
摘要
Osteosarcoma (OS) is the most common primary malignant bone tumor in children and young adults and has a poor prognosis. Recent developments in the field of high-throughput sequencing technology, particularly in methylated RNA immunoprecipitation sequencing (MeRIP-seq), have led to renewed interest in RNA methylation. Among the various RNA modifications, N6-methyladenosine (m6A) modifications are the most common. Emerging evidence suggests that m6A methylation can affect the complexity of cancer progression by regulating biological functions related to cancer. In this review, we will shed light on recent findings regarding the biological function of m6A methylation in OS and discuss future research directions and potential clinical applications of RNA methyltransferases in OS.
引用
收藏
相关论文
共 392 条
[31]  
Ory B(2014)A METTL3–METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation Nat Chem Biol 49 18-725
[32]  
Lamoureux F(2014)Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase Cell Res 14 e1007412-1185
[33]  
Harrison DJ(2018)VIRMA mediates preferential m(6)A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation Cell Discov 22 750-1736
[34]  
Geller DS(2011)N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO Nat Chem Biol 67 2254-1715
[35]  
Gill JD(2013)FTO-mediated formation of N6-hydroxymethyladenosine and N6-formyladenosine in mammalian RNA Nat Commun 38 857-167
[36]  
Lewis VO(2013)ALKBH5 Is a mammalian RNA Demethylase that impacts RNA metabolism and mouse fertility Mol Cell 38 101801-576
[37]  
Gorlick R(2021)YTH domain proteins: a family of m6A readers in cancer progression Front Oncol 11 632934-2593
[38]  
Chen Y(2017)YTHDC1 mediates nuclear export of N(6)-methyladenosine methylated mRNAs Elife 20 285-4402
[39]  
Hong T(2018)Nuclear m6A reader YTHDC1 regulates alternative polyadenylation and splicing during mouse oocyte development Plos Genet 10 536875-1165
[40]  
Wang S(2020)YTHDF1 Facilitates the progression of hepatocellular carcinoma by promoting FZD5 mRNA translation in an m6A-dependent manner Mol Ther Nucleic Acids 9 9430-6264